Category: Regulatory Updates

The Regulatory Updates category provides timely coverage of new guidelines, draft revisions, and official communications from authorities such as the EMA, FDA, ICH, USP, and Ph. Eur. It highlights regulatory changes that affect GMP operations, product development, and quality systems.

Each update is presented with context, showing what it means for manufacturers, QA/RA professionals, Qualified Persons, and supply chain leaders. Topics range from revisions to GMP chapters and data integrity expectations to draft guidance on testing and validation.

If you don’t find what you are looking for, try using a different term or contact us.

USP Introduces New Chapter for Early Adoption Non-Animal Derived Endotoxin Testing Methods

USP Introduces Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents for Early Adoption

USP releases early adoption guidelines for non-animal endotoxin testing, promoting sustainable recombinant Factor C methods with strict validation standards....
Draft EDQM General Chapter 5.38 Quality of Data

Draft EDQM General Chapter 5.38: Quality of Data

EDQM releases draft chapter 5.38 on data quality in pharma, emphasizing standards, governance, and SME involvement....
FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs

FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs

FDA's 2024 guidance on nitrosamine impurities introduces new limits, testing methods, and timelines, focusing on NDSRIs to enhance drug safety...
EDQM Publishes Revised Ph. Eur. Water Monographs for Feedback

EDQM Publishes Revised Ph. Eur. Water Monographs for Feedback

EDQM releases updated Ph. Eur. water monographs, including key changes to Water for Injection, Purified Water, and TOC standards. Open...
EDQM Presents 10 Deficiencies in New CEP Applications for Chemical Purity

EDQM Presents 10 Common Deficiencies in New CEP Applications for Chemical Purity

EDQM comes with a comprehensive summary of the top 10 deficiencies that were observed during the evaluation of CEP applications...
Topical Ophthalmic Drug Products

FDA Releases New Draft Guidance on Quality Considerations for Topical Ophthalmic Drug Products

Explore the FDA's latest draft guidance for top-notch quality in topical ophthalmic drug products. Stay informed on key considerations for...
Swissmedicines Inspectorate

SwissMedicines Inspectorate: Interpretation of GMP Annex 1 [2022]

Swissmedicines Inspectorate interprets the 2022 GMP Annex 1 guidelines, offering crucial insights into pharmaceutical manufacturing quality. Stay informed with GMP...

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!